First-in-human trial of a self-expandable, temporary dilation system for intracranial atherosclerotic disease in patients presenting with acute ischemic stroke.
Tsuyoshi OhtaMasataka TakeuchiHiroshi YamagamiKazuma TsutoShiro YamamotoKatsunori AsaiAkira IshiiHirotoshi ImamuraShinichi YoshimuraRyu FukumitsuChiaki SakaiNobuyuki SakaiSatoshi TateshimaPublished in: Journal of neurointerventional surgery (2023)
Acute revascularization using the TG dilator on patients with ICAD-related LVO or severe stenosis did not cause any significant adverse event, and consistently improved blood flow at 90 days.
Keyphrases
- acute ischemic stroke
- blood flow
- drug induced
- endothelial cells
- liver failure
- study protocol
- respiratory failure
- clinical trial
- phase iii
- induced pluripotent stem cells
- percutaneous coronary intervention
- pluripotent stem cells
- early onset
- coronary artery bypass grafting
- phase ii
- aortic dissection
- randomized controlled trial
- coronary artery disease
- optic nerve
- extracorporeal membrane oxygenation
- optical coherence tomography
- acute respiratory distress syndrome